J Korean Med Sci.  1991 Sep;6(3):206-213. 10.3346/jkms.1991.6.3.206.

Clinical usefulness of alpha-1-antitrypsin in the diagnosis of hepatocellular carcinoma

Affiliations
  • 1Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea.

Abstract

Serum levels of alpha-1-Antitrypsin(AAT) were determined in 42 patients with hepatocellular carcinoma(HCC), 5 patients with metastatic liver cancer from stomach adenocarcinoma, 10 patients with liver cirrhosis, 10 patients with chronic hepatitis, and 66 controls by rocket immunoelectrophoresis using rabbit antiserum. The mean level of serum AAT was 225.5 +/- 73.0 mg/dl in 66 controls. The serum AAT in patients with HCC was 428.7 +/- 123.3 mg/dl, which was significantly higher than those in the controls and in patients with liver cirrhosis or chronic hepatitis(p less than 0.02). The level of AAT in metastatic liver cancer was similar to that in HCC. The positive cut-off value for elevation of serum AAT in this study was determined as above 445 mg/dl, the mean plus 3 standard deviations in the controls. Elevations of serum AAT were observed in 54.8%, 60.0%, and 10.0% of patients with HCC, metastatic liver cancer, and liver cirrhosis, respectively, while none of the patients with chronic hepatitis or the controls was positive. The serum AAT levels in 42 patients with HCC were analyzed with regard to sex, age, serum albumin, HBsAg, alpha-fetoprotein(AFP), and diameter of HCC, with no significant differences being observed between these factors and the serum AAT levels except for the diameter of the HCC. The positive rate in the HCC with a diameter of 10 cm or more was 74.1%, which was a significantly higher rate compared with 20.0% in the HCC with diameters less than 10cm. The positive rate of AFP for HCC was 61.9%, when 500 ng/ml of AFP was used as the cut-off value.(ABSTRACT TRUNCATED AT 250 WORDS)

Keyword

Serum alpha-1-antitrypsin; Tumor marker; Hepatocellular carcinoma

MeSH Terms

Adult
Aged
Carcinoma, Hepatocellular/blood/*diagnosis
False Negative Reactions
False Positive Reactions
Female
Humans
Liver Neoplasms/blood/*diagnosis
Male
Middle Aged
Tumor Markers, Biological/*blood
alpha 1-Antitrypsin/*analysis
Tumor Markers, Biological
alpha 1-Antitrypsin
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr